| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/17/2002 | CN1344743A Human testicular development specific protein-26 gene encoding protein |
| 04/17/2002 | CN1344742A Human testicualr development specific protein-24 gene encoding protein |
| 04/17/2002 | CN1344741A Human testicular development specific protein-21 gene encoding protein |
| 04/17/2002 | CN1344740A Human testicular development specific protein-20 gene encoding protein |
| 04/17/2002 | CN1344739A Human testicular development specific protein-20B gene encoding protein |
| 04/17/2002 | CN1344738A Human testicular development specific protein-18 gene encoding protein |
| 04/17/2002 | CN1344737A Human testicular development specific protein-5 gene encoding protein |
| 04/17/2002 | CN1344736A 9-0-acetyl esterase gene encoding protein |
| 04/17/2002 | CN1344735A Human testicular development specific protein-19 gene encoding protein |
| 04/17/2002 | CN1344564A Prepn of polymyxin E sulfate injection |
| 04/17/2002 | CN1082795C Feed and feed additive for crustacean |
| 04/16/2002 | US6372899 Purified genes encoding mammalian cell surface antigens; proteins and antibodies |
| 04/16/2002 | US6372896 Kits for detecting fOHY030 |
| 04/16/2002 | US6372892 Interleukin—1 Hy2 materials and methods |
| 04/16/2002 | US6372890 Water-soluble polypeptides |
| 04/16/2002 | US6372888 Useful for combating fungal diseases in agricultural, pharmaceutical or preservative applications |
| 04/16/2002 | US6372887 Used to protect an animal from flea infestation |
| 04/16/2002 | US6372886 Useful for expression of the kringle domains and to the production of antibodies to human lipoprotein |
| 04/16/2002 | US6372883 For therapy and prophylaxis of infections caused by hepatitis c, hepatitis g and human gb viruses |
| 04/16/2002 | US6372794 Antiarthritic agents |
| 04/16/2002 | US6372784 Bismuth-containing compounds in topical dosage forms for treatment of corneal and dermal wounds |
| 04/16/2002 | US6372778 Sulfonamide inhibitors of aspartyl protease |
| 04/16/2002 | US6372744 β-sheet mimetics and methods relating to the use thereof |
| 04/16/2002 | US6372726 Methods of cancer treatment using NAALADase inhibitors |
| 04/16/2002 | US6372717 Acylated tyrosine-arginine dipeptide; applying skin lotion topically; sensitivity; analgesics, wound healing agents |
| 04/16/2002 | US6372716 Freeze dried mixture with glycine, polysorbate, sucrose, and histidine; storage stability |
| 04/16/2002 | US6372715 Use of erythropoientin and iron preparations for producing pharmaceutical combination preparations for treating rheumatic diseases |
| 04/16/2002 | US6372713 Administering peptide to relieve stress; side effect reduction |
| 04/16/2002 | US6372712 Complex of peptidyl-propyl cis/trans isomerase and drug such as rapamycin, cyclosporin a, fk-506, or other antibiotic |
| 04/16/2002 | US6372711 Receptor binding assay using polypeptide have contiguous sequence of extracellular domain or polypeptide mutein genetically engineered by insertion, deletion, or replacement |
| 04/16/2002 | US6372501 Glucose responsive β-cell line |
| 04/16/2002 | US6372494 Culturing fibroblast cells in three-dimensions in a cell culture medium; removing conditioned medium from the cultured cells; combining conditioned medium with a pharmaceutically acceptable carrier |
| 04/16/2002 | US6372493 Hormone-secreting cells maintained in long-term culture |
| 04/16/2002 | US6372492 Antisense modulation of talin expression |
| 04/16/2002 | US6372490 Nucleic acid encoding the MDM interacting protein |
| 04/16/2002 | US6372488 AMPA-binding human GluR4 receptors |
| 04/16/2002 | US6372487 Polynucleotides encoding peptide release factor, prfC (RF-3), a GTP-binding protein |
| 04/16/2002 | US6372474 To deacylate the acyl side chain of a cyclic lipopeptide compound |
| 04/16/2002 | US6372473 Tissue plasminogen activator-like protease |
| 04/16/2002 | US6372471 Cloning and recombinant production of vespid venom enzymes, such as phospholipase and hyaluronidase, and immunological therapies based thereon |
| 04/16/2002 | US6372468 Useful in the development of human therapeutics and diagnostic formulations |
| 04/16/2002 | US6372456 In diagnosis methods for detecting central nervous system and immune system-related disorders and in therapy |
| 04/16/2002 | US6372454 Also vectors, host cells; screening methods for identifying agonists or antagonists of follistatin-3 activity; diagnostic methods for detecting reproductive system and cell differentiation disorders and treating these |
| 04/16/2002 | US6372453 Neurturin receptor |
| 04/16/2002 | US6372452 Process for obtaining plant peptones with a high hydrolysis degree and applications thereof |
| 04/16/2002 | US6372443 Cassette for expressing a toxoplasma gondii P30 protein |
| 04/16/2002 | US6372441 Detecting the expression of the variable exon v10 in the cd44 gene in a patient or in a sample obtained from a patient, wherein the expression of the variable exon v10 in the cd44 gene indicates hodgkin's lymphomas |
| 04/16/2002 | US6372438 Obtaining transformed mammalian cells comprising a recombinant nucleic acid encoding a hpdgf-r polypeptide; incubating transformed mammalian cells with compound, and incubating witout compound; comparing activation in test cells |
| 04/16/2002 | US6372433 Antisense modulation of inhibitor of DNA binding-1 expression |
| 04/16/2002 | US6372431 Mammalian toxicological response markers |
| 04/16/2002 | US6372427 Cooperative oligonucleotides |
| 04/16/2002 | US6372264 Method of reducing calcified arterial plaque buildup and cellular malfunction and for balancing ionic calcium |
| 04/16/2002 | US6372263 Extracted from fertilized ovum of a sea water fish or a fresh water fish |
| 04/16/2002 | US6372262 Serum-derived factor inducing cell differentiation and medical uses thereof |
| 04/16/2002 | US6372260 Incorporation of active substances in carrier matrixes |
| 04/16/2002 | US6372258 Methods of spray-drying a drug and a hydrophobic amino acid |
| 04/16/2002 | US6372257 Compositions and methods for forming and strengthening bone |
| 04/16/2002 | US6372250 Non-invasive gene targeting to the brain |
| 04/16/2002 | US6372249 Senscent cell-derived inhibitors of DNA synthesis |
| 04/16/2002 | US6372229 Curing water soluble proteinaceous material and di- or polyaldehyde |
| 04/16/2002 | US6372228 Method of producing elastin, elastin-based biomaterials and tropoelastin materials |
| 04/16/2002 | US6372226 Intrathecal administration to a human patient of a neurotoxin such as botulinum toxin type a |
| 04/16/2002 | US6372224 Vaccine from isolated s protein |
| 04/16/2002 | US6372219 Parasite-derived anti-inflammatory immunomodulatory protein |
| 04/16/2002 | US6372218 Interferon dosage form and method therefor |
| 04/16/2002 | US6372217 Methods for the treatment of CD7+ viral infection with TXU-7-PAP |
| 04/16/2002 | US6372216 Hyperconcentration of hepatitis virus c neutralizing antibodies |
| 04/16/2002 | US6372215 Monoclonal antibodies to human CD6 |
| 04/16/2002 | US6372213 Method of treating sickle cell disease or thalassemia |
| 04/16/2002 | US6372212 Chitinase materials and methods |
| 04/16/2002 | US6372207 IFNAR2/IFN complex |
| 04/16/2002 | US6372206 Orally-administered interferon-TAU compositions and methods |
| 04/16/2002 | US6371992 Acellular matrix grafts: preparation and use |
| 04/16/2002 | US6371975 Compositions, systems, and methods for creating in situ, chemically cross-linked, mechanical barriers |
| 04/16/2002 | CA2359650A1 Pharmaceutical preparations and methods for inhibiting tumors |
| 04/16/2002 | CA2355334A1 Pharmaceutical preparations and methods for inhibiting tumors |
| 04/16/2002 | CA2321256A1 Pharmaceutical preparations and methods for inhibiting tumours |
| 04/16/2002 | CA2217565C Method for preventing and treating sensorineural hearing loss and vestibular disorders using glial cell line-derived neurotrophic factor (gdnf) protein product |
| 04/16/2002 | CA2184195C Screening method for identifying ligands for target proteins |
| 04/16/2002 | CA2115644C Duplex printer |
| 04/16/2002 | CA2088980C Pro-drugs for cck antagonists |
| 04/16/2002 | CA2046607C Inhibiting transformation of cells having elevated purine metabolic enzyme activity |
| 04/13/2002 | CA2321189A1 Antisense oligonucleotides directed toward mammalian vegf receptor genes and uses thereof |
| 04/11/2002 | WO2002029403A1 Gata-3 expression inhibitor and method of screening the same |
| 04/11/2002 | WO2002029105A1 INHIBITION OF TGF-β AND USES THEREOF |
| 04/11/2002 | WO2002029098A2 Genetic factors affecting the outcome of viral infections |
| 04/11/2002 | WO2002029088A2 Highly expressible genes |
| 04/11/2002 | WO2002029086A2 Nucleic acid sequences differentially expressed in cancer tissue |
| 04/11/2002 | WO2002029084A2 Industrial-scale serum-free production of recombinant factor vii in mammalian cells |
| 04/11/2002 | WO2002029083A2 Industrial-scale serum-free production of recombinant proteins in mammalian cells |
| 04/11/2002 | WO2002029072A2 Targetting molecules for adenoviral vectors |
| 04/11/2002 | WO2002029066A1 Antisense inhibition of caspase 6 expression |
| 04/11/2002 | WO2002029061A2 G-protein coupled receptors |
| 04/11/2002 | WO2002029060A2 Hematopoietin receptors hpr1 and hpr2 |
| 04/11/2002 | WO2002029059A2 Nogo receptor homologs |
| 04/11/2002 | WO2002029058A2 Human proteins, polynucleotides encoding them and methods of using the same |
| 04/11/2002 | WO2002029055A2 Carbohydrate-associated proteins |
| 04/11/2002 | WO2002029053A1 Novel g protein-coupled receptor protein and dna thereof |
| 04/11/2002 | WO2002029052A2 Regulation of human secretin receptor-like gpcr |
| 04/11/2002 | WO2002029051A2 Human secretin receptor-like gpcr |